Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Saad Mark E Create: Alert

All | News | Filings
Date FiledTypeDescription
06/06/2023 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 5,681 options to buy @ $74.12, valued at $421.1k
03/06/2023 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 2,224 options to buy @ $65.32, valued at $145.3k
06/07/2022 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 16,976 options to buy @ $25.53, valued at $433.4k
03/08/2022 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 2,337 options to buy @ $29.91, valued at $69.9k
11/19/2021 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Bought 3,000 shares @ $34.5324, valued at $103.6k
Bought 100 shares @ $34.395, valued at $3.4k
Bought 100 shares @ $34.45, valued at $3.4k
Bought 100 shares @ $34.4, valued at $3.4k
06/08/2021 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 7,325 options to buy @ $61.32, valued at $449.2k
03/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/07/2021 4 Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.
Txns: Granted 8,227 shares @ $0
10/14/2020 4 Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.
Txns: Granted 100,000 shares @ $0
06/05/2020 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 13,000 options to buy @ $77.38, valued at $1M
03/19/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2020 4 Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.
Txns: Granted 49,576 options to buy @ $1.18, valued at $58.5k
06/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.
Txns: Granted 29,850 shares @ $0
05/24/2019 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Bought 3,500 shares @ $22.33, valued at $78.2k
03/21/2019 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 29,387 options to buy @ $12.95, valued at $380.6k
10/05/2018 4 Saad Mark E (Director) has filed a Form 4 on Ra Medical Systems, Inc.
Txns: Granted 8,235 shares @ $0
09/26/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
06/05/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2018 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 32,602 options to buy @ $2.85, valued at $92.9k
03/17/2017 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
06/01/2016 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 6,231 options to buy @ $8.02, valued at $50k
11/24/2015 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Converted 3,502 shares @ $5.94, valued at $20.8k
Granted 3,502 convertible notes @ $5.94, valued at $20.8k
11/23/2015 4 Saad Mark E (Director) has filed a Form 4 on Axsome Therapeutics, Inc.
Txns: Granted 9,127 options to buy @ $9, valued at $82.1k
04/15/2014 4 Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns: Granted 170,000 options to buy @ $2.38, valued at $404.6k
02/04/2013 4 Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns: Disposed/sold 14,070 shares @ $0
Granted 150,000 options to buy @ $2.74, valued at $411k
Granted 75,000 options to buy @ $5, valued at $375k
03/14/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
01/30/2012 4 Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns: Disposed/sold 33,500 shares @ $0
Granted 33,500 shares @ $0
Granted 20,000 shares @ $0
Granted 40,000 options to buy @ $3.44, valued at $137.6k
08/12/2011 4 Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns: Bought 2,600 shares @ $3.1, valued at $8.1k
Bought 400 shares @ $3.12, valued at $1.2k
Bought 800 shares @ $3.13, valued at $2.5k
Bought 2,700 shares @ $3.14, valued at $8.5k
03/01/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
01/31/2011 4 Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns: Granted 50,000 options to buy @ $5.57, valued at $278.5k
05/21/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/09/2010 4 Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.
Txns: Granted 100,000 options to buy @ $6.71, valued at $671k
02/02/2009 4 Saad Mark E (CFO) has filed a Form 4 on CYTORI THERAPEUTICS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy